Anti-snoring treatment market seen reaching $3.78 billion by 2030

The anti-snoring treatment market is projected to grow from $2.54 billion in 2025 to $3.78 billion by 2030, driven by sleep disorder prevalence, higher healthcare spending and wider access to devices and therapies. North America led the market in 2025, while digital monitoring, personalized therapies and online sales are expected to shape the next phase of growth.

Why it matters: - Anti-snoring treatments target sleep disruption linked to snoring, airway blockage, muscle relaxation and nasal congestion. - Market growth reflects rising demand for products that improve sleep quality and may help reduce complications tied to disrupted breathing during rest. - The outlook points to broader adoption of non-invasive and home-based solutions as more consumers look for accessible sleep health options.

What happened: - The Business Research Company projected the anti-snoring treatment market will rise from $2.54 billion in 2025 to $2.76 billion in 2026. - The report forecasts the market will reach $3.78 billion by 2030. - The forecast implies 8.5% CAGR from 2025 to 2026 and 8.2% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - Historical growth has been driven by higher incidence of sleep-related breathing disorders, greater awareness of sleep health, easier access to over-the-counter snoring devices, expansion of sleep clinics and wider use of oral appliance therapies. - Future growth is expected to come from digital sleep monitoring, personalized sleep therapy, online sales channels, preventive sleep health and demand for minimally invasive treatments. - Expected trends include smart wearable anti-snoring devices, non-invasive options, home-based solutions, personalized oral appliance therapies and a stronger focus on sleep quality. - The company said the 2026 report package includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report is available with a free sample and a full market report.

Between the lines: - The market is shifting from basic snoring devices toward connected, personalized and at-home treatment models. - Rising healthcare spending strengthens access to diagnostics and treatment, which can widen the addressable market for snoring-related products. - US national health expenditures grew 7.5% in 2023 to $4.9 trillion, equal to $14,570 per person and 17.6% of GDP, according to federal data cited in the report. - Medicare spending rose 8.1% to $1,029.8 billion, or 21% of total health expenditures. - A November 2023 UK National Health Service report said 64.9% of people aged 17 to 23 reported sleep problems three or more times per week, up from 64.0% in 2022.

What's next: - Market growth will likely depend on how quickly digital monitoring tools and personalized therapies move into mainstream sleep care. - Online sales and home-use devices are positioned to capture more demand if consumers continue favoring convenience and less invasive treatment options. - North America is expected to remain a major market as healthcare spending and awareness stay elevated.

The bottom line: - Anti-snoring treatments are moving from a niche device category into a broader sleep-health market, with steady growth projected through 2030.